Integrated genomic and epigenomic analysis of breast cancer brain metastasis
about
Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastasesBreast Cancer Brain Metastases: Clonal Evolution in Clinical Context.DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumorsPromoter hypermethylation profiling of distant breast cancer metastases.Organ-specific adaptive signaling pathway activation in metastatic breast cancer cellsCytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics.Nitric Oxide Regulates Gene Expression in Cancers by Controlling Histone Posttranslational Modifications.Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.Comparative genomic analysis reveals bilateral breast cancers are genetically independentChanging molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomesMolecular biology of brain metastasis.Brain metastasis: new opportunities to tackle therapeutic resistance.Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants.Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon?Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor.Breast cancer brain metastases: Molecular subtype, treatment and survival.Advances in decoding breast cancer brain metastasis.Genome-wide analysis of DNA methylation and their associations with long noncoding RNA/mRNA expression in non-small-cell lung cancer.Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer.High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD.ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker.Comprehensive molecular biomarker identification in breast cancer brain metastases.Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis.SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner.Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies.Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancer.ATM in breast and brain tumors: a comprehensive review
P2860
Q26750508-FAD41805-5C19-4C9C-92DE-96257C1C43EAQ30238959-D31DECFA-15D8-4629-B35C-D0AB418674D0Q34694198-D81897D3-7474-4D52-9043-AE928CCB0D72Q35000289-CE02247E-E389-4F34-AD95-3E750077EB8EQ35176075-730EDA38-5BA7-4A15-BEEF-7F8C5D4A0369Q35533772-B2D40A76-06CD-4228-ABAD-DD832A42E087Q35828652-5785B600-352F-40BB-A00F-B1477A30631FQ35987423-4D464A2B-924B-4F6B-A4BC-2680E823F6DEQ36378173-B69DD6C8-F637-4D27-AA6E-3AAE389CAA2BQ36495170-9FC0DC2C-20F8-4D8A-A183-4E26492F3D70Q36544696-89EF13E2-6FD2-4F29-8976-2A39AC82D8DEQ37174919-E692551F-B3F3-4CA7-94F0-E9767F383051Q38216231-2B8FC731-BA25-4E41-9A7D-42E28579F363Q38222247-5B7C7C82-F5DA-434F-96DA-26D0E8008B4DQ38603013-6D5ECB5A-566A-4045-A48E-AC889ECE7847Q38616628-492ED3F9-B7C0-444C-A3C8-470C5FD92016Q38790859-1109A1F9-A8BC-4938-BB0A-BAD887DFC2A2Q38996026-425B7046-71A6-4918-9C3C-91C717CA8627Q39016244-30E2E3FF-0042-4714-88CC-E11BFACBC09DQ40368914-5E9959E6-6DE4-4CAA-8B94-2A97711B7D44Q40528885-B2ADD126-D858-487C-B18F-C8B6208DBFC1Q40656900-E75E6737-98D5-46DB-BFB6-50F4212FC39AQ41156328-306D6937-BCFD-4665-8675-5004C881D380Q47098306-1227ACB2-115D-4533-A384-A7B3FFCEF404Q48471112-C8951F05-72A9-4103-A294-C168AEDED740Q49082801-32149E05-B080-4327-A2F4-FA14730F7891Q50190951-A08650D4-DD91-4AF2-837B-1EF66EFFFD9EQ51012619-1B7F2889-7D66-45F9-8C18-BA9E1ADE2810Q55158192-879A8CD7-17B2-4BD4-BCB8-EC1CB6EA049DQ55287222-C56B726F-EC17-405C-85A3-F10A48780387Q55493581-0C0CC9A8-AFE3-465A-BC8F-626A07AD3231Q58804970-943FB267-159B-4E64-9576-4129C879DF8B
P2860
Integrated genomic and epigenomic analysis of breast cancer brain metastasis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Integrated genomic and epigenomic analysis of breast cancer brain metastasis
@en
Integrated genomic and epigenomic analysis of breast cancer brain metastasis.
@nl
type
label
Integrated genomic and epigenomic analysis of breast cancer brain metastasis
@en
Integrated genomic and epigenomic analysis of breast cancer brain metastasis.
@nl
prefLabel
Integrated genomic and epigenomic analysis of breast cancer brain metastasis
@en
Integrated genomic and epigenomic analysis of breast cancer brain metastasis.
@nl
P2093
P2860
P1433
P1476
Integrated genomic and epigenomic analysis of breast cancer brain metastasis
@en
P2093
Angela Baker
Bodour Salhia
Danielle M DiPerna
Emanuel F Petricoin
Garrick Wallstrom
Jeff Kiefer
John Carpten
Julianna T D Ross
Kimberly M Paquette
P2860
P304
P356
10.1371/JOURNAL.PONE.0085448
P407
P577
2014-01-29T00:00:00Z